Current U.S. Student

United States citizens who are currently enrolled in undergraduate or graduate degree programs are eligible to apply. All applicants enrolled in U.S institutions must apply through their home campuses. Find the Fulbright Program Adviser on your campus.

If you are an undergraduate student, you are eligible to apply in the fall of your senior year.  If you are a graduate student, you are eligible as long as you will not have a PhD degree by the application deadline.

U.S. Citizen but not a Student

If you are a U.S. citizen, hold a bachelor’s degree, and do not have a PhD degree, then you are eligible to apply. Non-enrolled applicant should have relatively limited professional experience in the fields (typically 7 years or less) in which they are applying. Candidates with more experience should consider applying for the Fulbright Scholar Program.
Please review the program summary for the country where you would like to apply.

Artist

The Fulbright U.S. Student Program welcomes applications in the creative and performing arts. Arts candidates for the U.S. Student Program should have relatively limited professional experience in the fields (typically 5 years or less) in which they are applying. Artists with more experience should consider applying for the Fulbright Scholar Program.

Creative & Performing Arts projects fall under the Study/Research grant category and are available in all countries where Study/Research grants are offered. 

FPA

Placeholder

U.S. Professor

If you are a U.S. citizen and a professor at a U.S. institution and are interested in applying for a Fulbright Scholar Award, you will need to apply through CIES.

Non U.S. Citizens

If you are a non-U.S. citizen interested in applying for a Fulbright Award to the United States, you will need to apply through the Fulbright Commission or U.S. Embassy in your home country. Find out more information on the Fulbright Visiting Scholar or Student Program.

Malawi

< Back to country

3 Fulbright-Fogarty Public Health Fellowship Awards

Accepted Degree Levels
Doctoral
Grant Period
9 Months
PDO
Mandatory
Award Profile

The Fulbright-Fogarty fellowship in Malawi offers U.S. graduate and post-graduate students in the health sciences practical experience designing and conducting clinical research in Malawi. 

Affiliation: UNC Project – Malawi

Background: UNC has had a presence in Malawi since 1990. UNC Project-Malawi, a collaboration between UNC and the Malawi Ministry of Health, was established in 1999 on the campus of Kamuzu Central Hospital in Lilongwe. UNC Project’s current portfolio of activities spans clinical service delivery, public health program implementation, and clinical and operational research focused on HIV and STDs, other infectious diseases such as malaria and tuberculosis, emergency obstetrics, cancer, family planning, surgery and trauma.  

Fulbright-Fogarty Students in Malawi may work in the following areas: 

UNC Project-Malawi Enrolling studies Cervical Cancer Screening study: This cluster randomized trial will randomize 16 health facilities in Lilongwe and Zomba districts to 2 different HPV-based cervical cancer screen-and-treat strategies. Its objectives are to compare the acceptability, uptake, effectiveness, and cost-effectiveness of the 2 strategies. The study will be implemented between September 2019-March 2021. Contact: Lameck Chinula, Jennifer Tang

KCH Lymphoma study: This is an ongoing longitudinal cohort, initiated in 2013, of adults and children with pathologically confirmed lymphoproliferative disorders receiving standardized treatment under local conditions at Kamuzu Central Hospital. The study focuses on clinical presentation, treatment, and outcomes, with embedded virologic, biomarker, and genomic correlative studies, and includes a pilot clinical trial evaluating safety and efficacy of the anti-CD20 monoclonal antibody rituximab in this environment. Contact: Satish Gopal

Breast cancer cohort study: This study started in 2017, is developing a clinically annotated cohort of breast cancer cases at Kamuzu Central Hospital. It will establish a tumor block repository for future molecular and genomic characterization and collect data from patients on risk factors and post-treatment outcomes. Contact: Tamiwe Tomoka, MBBS; Satish Gopal MD, MPH

SHARP: This is a five-year project focused on mental health treatment capacity in Malawi and Tanzania. We will conduct implementation science research focused on scaling up mental health treatment in non-communicable diseases clinics in Malawi; provide training courses in implementation science research, mental health interventions, and translation of research to policy; and support pilot projects focused on mental health implementation science and research-to-policy translation. Contact: Brian Pence

Perinatal depression study: This 3-year intervention development grant has completed formative work to guide adaptation of a depression counseling tailored to the needs of women living with HIV during the perinatal period, and will be implementing a six-clinic randomized pilot study to evaluate the intervention’s acceptability and feasibility for a larger trial. Contact: Brian Pence

TBM Kids: This trial is investigating the optimization of tuberculous meningitis (TBM) treatment in children hospitalized at Kamuzu Central Hospital with TBM. Children diagnosed with TBM at KCH either receive standard of care medications per WHO guidelines or receive a high dose rifampicin with or without levofloxacin within intensive phase of TBM treatment. Study recruitment began in June 2017. Target accrual for Lilongwe site is 30 patients and duration of follow up per patient is 12 months. Contact: Tisu MvaloAMBITION: This trial is comparing 2 strategies for treating HIV associated Cryptococcal Meningitis in adults hospitalized at Kamuzu Central Hospital. HIV infected individuals with cryptococcal meningitis are randomized to single high-dose liposomal Amphotericin (experimental) or 7 days of standard Amphotericin (Standard of Care) as a part of combination antifungal therapy. Contact: Cecilia Kanyama, Mina Hosseinipour

Malaria Vaccine Implementation Program (MVIP): Malawi is one of 3 countries in Africa in which there will be a pilot exercise on the administration of the RTS’S malaria vaccine as per recommendations from WHO. The aims of this pilot exercise are: to assess the feasibility vaccination per proposed dose schedule, assess the impact on mortality in the clusters where the vaccine is administered and to further assess the safety of the RTS’S though hospital surveillance. This exercise is planned to take place across Malawi. A consortium of research partners has been formed to carry out this evaluation of which UNC Project will primarily work in 2 districts (Lilongwe and Ntchisi). The UNC team will lead the evaluation of the safety assessment objective across 4 sentinel district hospitals in Malawi. Vaccine administration and the evaluation exercise is targeted to commence in the second quarter of 2019. Contact: Tisu Mvalo, Irving Hoffman

Data Analysis and Manuscript Focused ProjectsOption B+ PMTCT study: This study evaluates the safety of first and second line treatments among HIV infected pregnant women and their infants. There are multiple aims related to safety, viral suppression, opportunistic infection, neurocognitive development of infants, and understanding defaulters. All data collection will be completed and a trainee will focus on data analysis and manuscript preparation. Contact: Mina Hosseinipour

Kaposi sarcoma cohort: Patients with KS at Lighthouse Trust and the KCH Cancer Clinic are enrolled in a longitudinal cohort similar to the lymphoma study, with a focus on clinical and molecular predictors of outcomes. Contact: Satish Gopal

Malawi HIV-cancer match study: Data from the Malawi National Cancer Registry are linked to HIV cohort data in a large epidemiologic study to assess cancer burden in the HIV-infected population and changes over time with availability of antiretroviral therapy. Contact: Satish Gopal

U.S. Partner:

UJMT Fogarty Global Health Fellowship

Site Contacts:

Site Director: Mina Hosseinipour, MD, MPH

Project Contact: Dr. Ben Chi, benjamin_chi@med.unc.edu

Project Contact: Ms. Kathryn Salisbury, ksals@med.unc.edu

Grant Period

9 Months

Grants are for 9-10 months during the period of August 1 – June 30.

Pre-Departure Orientation

Mandatory

Grantees will be required to participate in a Pre-Departure Orientation with NIH in July 2020.

Candidate Profile

Candidates must fall under one of the following categories: Post-third year medical school; Post graduation from medical school; Ph.D. students in health sciences (post-Master’s-level), and must be enrolled in an accredited doctoral level program (MD, PhD or equivalent).  The MD students must have completed their 3rd year and the PhD candidates must have completed all their master's level coursework.

Accepted Degree Levels

Doctoral

Foreign Language Proficiency

Not Required

Additional Information: Although English is the official language, knowledge of the local language where one will be researching is an added advantage.

Fulbright Proposal Types

Independent Study/Research: Yes

Graduate Degree Enrollment: No

Affiliation

Applicants are required to obtain a letter of support from the site contact.  

When emailing project contacts, please include both contacts and attach a current CV and a concise statement (less than 500 words) about your interest in the program (especially your primary research interest).  

Special Application Instructions

Select "Fulbright-Fogarty" for Award Type in the application.  

All Fulbright-Fogarty applicants pursuing a placement in Malawi should select “Public Health” as the Field of Study in the Fulbright application. 

Dependents

Dependent support is available.

Fulbright Commission/U.S. Embassy Website

http://mv.usembassy.gov

Fulbright Commission/U.S. Embassy Contact

Public Affairs Section